Your browser doesn't support javascript.
loading
Respiratory insufficiency as a presenting symptom of congenital myasthenic syndromes.
van den Udenhout, Fleur; Merkus, Peter; Verhaagen-van den Akker, Sandra; Schouten, Meyke; Erasmus, Corrie; Braakman, Hilde.
Afiliação
  • van den Udenhout F; Department of Paediatric Neurology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Merkus P; Department of Paediatric Pulmonology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Verhaagen-van den Akker S; Department of Neurology, Deventer Hospital, Deventer, Netherlands.
  • Schouten M; Department of Human Genetics, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Erasmus C; Department of Paediatric Neurology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Braakman H; Department of Paediatric Neurology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.
Acta Paediatr ; 112(5): 1091-1096, 2023 05.
Article em En | MEDLINE | ID: mdl-36718955
ABSTRACT

AIM:

Respiratory insufficiency can be a presenting symptom of congenital myasthenic syndromes (CMS) but is rarely recognised as such. In this study, we aim to raise awareness of CMS to paediatricians.

METHODS:

We performed a retrospective case study of infants and preschool children treated in the past 5 years in Amalia Children's Hospital, Radboud University Medical Center in Nijmegen, the Netherlands for respiratory insufficiency as presenting symptom of CMS.

RESULTS:

Five children aged 2 weeks to 5 years experienced severe to life-threatening episodes of respiratory insufficiency, especially during viral infections, due to respiratory muscle weakness. During infections, they often also had progression of their otherwise mild ocular, facial, and limb muscle weakness. They were eventually diagnosed with genetically proven CMS. In these five children, treatment with pyridostigmine, an acetylcholinesterase inhibitor, resulted in clinical improvement.

CONCLUSION:

CMS should be considered in every patient with unexplained recurrent respiratory insufficiency, or with an unusually severe course of a normally mild respiratory infection, especially in combination with mild muscle weakness outside periods of illness. Early diagnosis of CMS is crucial for early treatment, which may help avoiding sudden infant death, severe respiratory insufficiency and further deterioration of the muscle strength.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Síndromes Miastênicas Congênitas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Child, preschool / Humans / Infant Idioma: En Revista: Acta Paediatr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Respiratória / Síndromes Miastênicas Congênitas Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Child, preschool / Humans / Infant Idioma: En Revista: Acta Paediatr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda